Skip to main content
. 2017 Aug 25;2017(8):CD010685. doi: 10.1002/14651858.CD010685.pub3

3. Response to treatment.

Response Primary tumour Metastatic sites
Complete response No tumour No tumour; catecholamines normal
Very good partial response Decreased by 90% to 99% No tumour; catecholamines normal; residual 99Tc bone changes allowed
Partial response Decreased by more than 50% All measurable sites decreased by > 50%. Bones and bone marrow: number of positive bone sites decreased by > 50%; no more than 1 positive bone marrow site allowed
Minimal response No new lesions; > 50% reduction of any measurable lesion (primary or metastases) with < 50% reduction in any other; < 25% increase in any existing lesion
No response No new lesions; < 50% reduction but < 25% increase in any existing lesion
Progressive disease Any new lesion; increase of any measurable lesion by > 25%; previous negative marrow positive for tumour

Reference: Brodeur 1993.